All In Biotech

Drug Trial Radar · NCT03956355

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)

A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Plaque Psoriasis in Adults

Last checked: Nov 20, 2026Latest source record: Jun 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 510 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

510

Actual

Start

May 21, 2019

Primary completion

May 26, 2020

Study completion May 26, 2020

Sponsor

Lead sponsor
Organon and CoIndustry
Sponsor type
Industry
Collaborators
IQVIA Biotech
First posted
May 20, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, double-blind, vehicle-controlled Phase 3 study to evaluate the efficacy and safety of topical tapinarof cream, 1% once daily for the treatment of plaque psoriasis in adults. Approximately 500 adult subjects with plaque psoriasis will be randomized 2:1 to receive either tapinarof cream, 1% or matching vehicle cream once daily for 12 weeks.

Conditions

  • Plaque Psoriasis

Interventions

  • TapinarofDrug

    Tapinarof cream, 1%, applied once daily

  • Vehicle CreamDrug

    Vehicle cream applied once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent of Subjects Who Achieve a Physician Global Assessment (PGA) Score of Clear (0) or Almost Clear (1) With a Minimum 2-grade Improvement From Baseline at Week 12. Analyses Were Done Using Multiple ImputationTime frame: Baseline to Week 12

Locations

53 sites in 2 countries. Site status is shown where the registry gives one.

  • Dermavant Investigative Site

    Birmingham, Alabama

  • Dermavant Investigative Site

    Phoenix, Arizona

  • Dermavant Investigative Site

    Hot Springs, Arkansas

  • Dermavant Investigative Site

    Rogers, Arkansas

  • Dermavant Investigative Site

    Anaheim Hills, California

  • Dermavant Investigative Site

    Fresno, California

  • Dermavant Investigative Site

    Los Angeles, California

  • Dermavant Investigative Site

    Northridge, California

  • Dermavant Investigative Site

    San Diego, California

  • Dermavant Investigative Site

    Santa Ana, California

  • Dermavant Investigative Site

    Cromwell, Connecticut

  • Dermavant Investigative Site

    Boca Raton, Florida

  • Dermavant Investigative Site

    Brandon, Florida

  • Dermavant Investigative Site

    Hialeah, Florida

  • Dermavant Investigative Site

    Miramar, Florida

  • Dermavant Investigative Site

    Marietta, Georgia

  • Dermavant Investigative Site

    Evansville, Indiana

  • Dermavant Investigative Site

    Indianapolis, Indiana

  • Dermavant Investigative Site

    New Albany, Indiana

  • Dermavant Investigative Site

    Louisville, Kentucky

  • Dermavant Investigative Site

    Owensboro, Kentucky

  • Dermavant Investigative Site

    Baton Rouge, Louisiana

  • Dermavant Investigative Site

    New Orleans, Louisiana

  • Dermavant Investigative Site

    New Orleans, Louisiana

  • Dermavant Investigative Site

    Boston, Massachusetts

  • Dermavant Investigative Site

    Clarkston, Michigan

  • Dermavant Investigative Site

    Warren, Michigan

  • Dermavant Investigative Site

    Saint Joseph, Missouri

  • Dermavant Investigative Site

    Verona, New Jersey

  • Dermavant Investigative Site

    Kew Gardens, New York

  • Dermavant Investigative Site

    New York, New York

  • Dermavant Investigative Site

    Rochester, New York

  • Dermavant Investigative Site

    Cary, North Carolina

  • Dermavant Investigative Site

    High Point, North Carolina

  • Dermavant Investigative Site

    Norman, Oklahoma

  • Dermavant Investigative Site

    Portland, Oregon

  • Dermavant Investigative Site

    Pittsburgh, Pennsylvania

  • Dermavant Investigative Site

    Johnston, Rhode Island

  • Dermavant Investigative Site

    Arlington, Texas

  • Dermavant Investigative Site

    College Station, Texas

Showing 40 of 53 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.